Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04624399
Title Phase 2 Study of Neoadjuvant Immune Checkpoint Inhibitors in Urothelial Cancer (ABACUS-2)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Queen Mary University of London
Indications

ureter transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

Therapies

Atezolizumab

Age Groups: adult | senior
Covered Countries

Facility Status City State Zip Country Details
Sheffield Teaching Hospitals NHS Foundation Trust Sheffield South Yorkshire S5 7AU United Kingdom Details
Clatterbridge Cancer Centre NHS Foundation Trust Liverpool United Kingdom Details
Barts and London Hospital NHS Trust London United Kingdom Details
University College London Hospitals NHS Foundation Trust London United Kingdom Details
Oxford University Hospitals NHS Foundation Trust Oxford United Kingdom Details
Southampton General Hospital Southampton United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field